Health
Why Moderna Stock Climbed Today – Motley Fool
One analyst sees gains of nearly 40% ahead for the biotech’s shareholders.
What happened
Shares of Moderna (NASDAQ:MRNA) rose 6.8% on Friday, as analysts and investors grew more optimistic about the vaccine maker’s growth prospects.
So what
Piper Sandler analyst Edward Tenthoff repeated his overweight rating on Moderna’s stock and boosted his price forecast from $208 to $234 on Thursday. His new price target represents potential returns to shareholders of roughly 37% from Moderna’s current share price near $170.
Moderna’s stock price is up sharply in recent days. Image…
-
Noosa News23 hours agoAbusive bus driver fired by council loses appeal
-
General19 hours agoIran’s currency at record low as tensions run high
-
General24 hours agoTigers and Lions fans forced to wait in long queues at the MCG after Thursday night’s security incident
-
Noosa News24 hours agoHundreds pack neighbourhood for no-reserve auction of ready-made charity home